{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:30:50Z","timestamp":1764588650724,"version":"3.40.4"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,28]]},"DOI":"10.7759\/cureus.83157","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:28:11Z","timestamp":1745904491000},"source":"Crossref","is-referenced-by-count":0,"title":["Daptomycin-Associated Acute Eosinophilic Pneumonia: A Case of a Severe Reaction"],"prefix":"10.7759","author":[{"given":"Ibrahim","family":"Shamasneh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neaam","family":"Al-Bahadili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel K","family":"Dadzie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Fox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-016-0158-8","article-title":"Daptomycin-induced eosinophilic pneumonia - a systematic review","volume":"5","author":"Uppal P","year":"2016","unstructured":"Uppal P, LaPlante KL, Gaitanis MM, Jankowich MD, Ward KE. Daptomycin-induced eosinophilic pneumonia - a systematic review. Antimicrob Resist Infect Control. 2016, 5:55. 10.1186\/s13756-016-0158-8","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2021.01.002","article-title":"Daptomycin-induced eosinophilic pneumonia: are there any risk factors?","volume":"51","author":"Ahouansou N","year":"2021","unstructured":"Ahouansou N, Georges M, Beltramo G, Aswad N, Hassani Y, Bonniaud P. Daptomycin-induced eosinophilic pneumonia: are there any risk factors?. Infect Dis Now. 2021, 51:618-21. 10.1016\/j.idnow.2021.01.002","journal-title":"Infect Dis Now"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10040446","article-title":"Risk factors of daptomycin-induced eosinophilic pneumonia in a population with osteoarticular infection","volume":"10","author":"Soldevila-Boixader L","year":"2021","unstructured":"Soldevila-Boixader L, Villanueva B, Ulldemolins M, et al.. Risk factors of daptomycin-induced eosinophilic pneumonia in a population with osteoarticular infection. Antibiotics (Basel). 2021, 10:446. 10.3390\/antibiotics10040446","journal-title":"Antibiotics (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009688","article-title":"Drug-induced eosinophilic pneumonia: a review of 196 case reports","volume":"97","author":"Bartal C","year":"2018","unstructured":"Bartal C, Sagy I, Barski L. Drug-induced eosinophilic pneumonia: a review of 196 case reports. Medicine (Baltimore). 2018, 97:e9688. 10.1097\/MD.0000000000009688","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2165\/11597460-000000000-00000","article-title":"Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports","volume":"35","author":"Kim PW","year":"2012","unstructured":"Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S. Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports. Drug Saf. 2012, 35:447-57. 10.2165\/11597460-000000000-00000","journal-title":"Drug Saf"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-024-02349-z","article-title":"Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series","volume":"52","author":"Gidari A","year":"2024","unstructured":"Gidari A, Pallotto C, Francisci D. Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series. Infection. 2024, 52:2145-68. 10.1007\/s15010-024-02349-z","journal-title":"Infection"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362496-daptomycin-associated-acute-eosinophilic-pneumonia-a-case-of-a-severe-reaction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:28:11Z","timestamp":1745904491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362496-daptomycin-associated-acute-eosinophilic-pneumonia-a-case-of-a-severe-reaction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":6,"URL":"https:\/\/doi.org\/10.7759\/cureus.83157","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,28]]}}}